Pharmaceuticals occupiers in Mexico City typically cluster in Insurgentes / Condesa-Roma, plan ~220 sqft per seat at high-end fit-out ($2600–3900/sqft), and pay around 580 MXN/sqft ($34 USD) on Class A.
Pharmaceuticals occupiers in Mexico City typically cluster in Insurgentes / Condesa-Roma, plan ~220 sqft per seat at high-end fit-out">fit-out ($2600–3900/sqft), and pay around 580 MXN/sqft ($34 USD) on Class A.
Pharmaceuticals occupiers in Mexico City typically anchor in Insurgentes / Condesa-Roma. Tech, creative agencies, advertising, hospitality, boutique professional services.
Class A rent in Mexico City runs 580 MXN/sqft ($34 USD) on a 5-year lease with 6 months free. Prime submarkets sit at or modestly above the city index.
Typical pharmaceuticals fit-out targets high-end specification at $2600–3900/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 220 sqft per seat blended (workstation + circulation + amenity). A 100-headcount pharma office in Mexico City typically targets 22,000 sqft of leasable area.
Commercial and medical-affairs teams cluster near academic-medical anchors; large floor plates support cross-functional brand teams. Deep banking, professional services, and engineering talent. Strong feed from UNAM, IPN, ITAM, Tec de Monterrey. Spanish-English bilingual professional base growing rapidly.
Headline corporate tax: 30%. Net leases. 5-7 year terms with renewal options. Free rent of 4-9 months and TI of MXN 1,200-2,200/sqm typical. Most trophy leases are USD-pegged for international tenants.
| city | Mexico City |
|---|---|
| industry | Pharmaceuticals |
| naics | 3254, 5417 |
| preferredSubmarket | Insurgentes / Condesa-Roma |
| preferredFitoutSpec | High-end |
| fitoutBand | $2600–3900/sqft |
| sqftPerSeat | 220 |
| classARentLocal | 580 MXN/sqft/yr |
| classARentUsd | $34/sqft/yr |
| vacancyPct | 22.6% |
| typicalLeaseYears | 5 |
| typicalRentFreeMonths | 6 |
| talentIndex | 78 |
| corporateTaxPct | 30% |
Reviewed by Miriam Hollander — Lead market analyst. Last updated 2026-04-15. See our methodology and editorial standards.